Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 10562-10562 ◽  
Author(s):  
Holger N. Lode ◽  
Dominique Valteau-Couanet ◽  
Sascha Troschke-Meurer ◽  
Carla Manzitti ◽  
Juliet Gray ◽  
...  
1994 ◽  
Vol 15 (1) ◽  
pp. 74-78 ◽  
Author(s):  
Michael J. Hawkins ◽  
Michael B. Atkins ◽  
Janice P. Dutcher ◽  
Richard I. Fisher ◽  
Geoffrey R. Weiss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document